LB
Luke del Balzo
Kidney NeoplasmsCarcinoma, Renal CellBrain NeoplasmsCD8-Positive T-Lymphocytescs.AIImmunotherapyRadiosurgeryAnilidesantigen-presenting cellsBiomarkers, Tumor
On Valency
published · living versionsW_mghnr9kn·v1 · currentpublished
A radiographic world model for clinical reasoning and evidence generation
with Suyang Xi, Songtao Hu, Shansong Wang, Mojtaba Safari +6
1 version
Preprints & journals
14 papers in the corpus · 2021–2026Cardiac Substructure Dose Quantification and Optimization in Left-Sided Lung Cancer Radiation Therapy.42727773 · Wildman, Vanessa L, Qiu, Richard L J, Luca, Kirk et al.2026 · 0 citationsPractical radiation oncology. 2026
A radiographic world model for clinical reasoning and evidence generation2609.07719v1 · Suyang Xi, Songtao Hu, Shansong Wang et al.2026 · 0 citationsarXivon Valency
Domain-adapted foundation model for automated cardiac CT substructure segmentation for thoracic radiotherapy.42242380 · Li, Yuheng, Wildman, Vanessa L, Balzo, Luke Del et al.2026 · 0 citationsRadiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 2026;221:111619
Evaluating GPT-5 as a Multimodal Clinical Reasoner: A Landscape Commentary2603.04763v1 · Alexandru Florea, Shansong Wang, Mingzhe Hu et al.2026 · 0 citationsarXiv
Neoadjuvant cabozantinib for locally advanced nonmetastatic clear cell renal cell carcinoma: a phase 2 trial.40016487 · Bilen, Mehmet A, Vo, BaoHan T, Liu, Yuan et al.2025 · 15 citationsNature cancer. 2025;6(3):432-444
Author Correction: Differentiation fate of a stem-like CD4 T cell controls immunity to cancer.39506126 · Cardenas, Maria A, Prokhnevska, Nataliya, Sobierajska, Ewelina et al.2026 · 2 citationsNature. 2024;635(8039):E9
Differentiation fate of a stem-like CD4 T cell controls immunity to cancer.39443797 · Cardenas, Maria A, Prokhnevska, Nataliya, Sobierajska, Ewelina et al.2024 · 64 citationsNature. 2024;636(8041):224-232
Neoadjuvant cabozantinib restores CD8+ T cells in patients with locally advanced non-metastatic clear cell renal cell carcinoma: a phase 2 trial.39149474 · Bilen, Mehmet A, Vo, BaoHan T, Liu, Yuan et al.2025 · 3 citationsResearch square. 2024
Clinical Outcomes and Targeted Genomic Analysis of Renal Cell Carcinoma Brain Metastases Treated with Stereotactic Radiosurgery.39107179 · Ma, Jennifer, Del Balzo, Luke, Walch, Henry et al.2025 · 4 citationsEuropean urology oncology. 2025;8(2):338-346
Artificial-intelligence-driven measurements of brain metastases' response to SRS compare favorably with current manual standards of assessment.38464949 · Prezelski, Kayla, Hsu, Dylan G, Del Balzo, Luke et al.2024 · 6 citationsNeuro-oncology advances. 2024;6(1):vdae015
Immune niches in brain metastases contain TCF1+ stem-like T cells, are associated with disease control and are modulated by preoperative SRS.36993444 · Jansen, Caroline S, Prabhu, Roshan S, Pagadala, Meghana S et al.2025 · 24 citationsResearch square. 2023
CD8+ T cell activation in cancer comprises an initial activation phase in lymph nodes followed by effector differentiation within the tumor.36580918 · Prokhnevska, Nataliya, Cardenas, Maria A, Valanparambil, Rajesh M et al.2023 · 370 citationsImmunity. 2023;56(1):107-124.e5
Clinical outcome following checkpoint therapy in renal cell carcinoma is associated with a burst of activated CD8 T cells in blood.35863822 · Carlisle, Jennifer Wilkinson, Jansen, Caroline S, Cardenas, Maria Andrea et al.2022 · 42 citationsJournal for immunotherapy of cancer. 2022;10(7)
A Subset of Localized Prostate Cancer Displays an Immunogenic Phenotype Associated with Losses of Key Tumor Suppressor Genes10.1101/2021.01.27.21250464v1 · Calagua, C., Ficial, M., Jansen, C. S. et al.2021 · 49 citationsmedRxiv
Career total: 32 works. 14 are in this corpus.
Profile built from the corpus for this byline.
Author records are still filling in while the Hub is in alpha. If this is your page, you'll be able to claim it soon. Spot a mistake? Tell us.